Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03017664 · ClinicalTrials.gov registry record
Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding
A clinical trial, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- 28
- Enrollment target
NCT03017664: Completed study, sponsored by Société des Produits Nestlé (SPN).
NCT03017664 is a clinical trial that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03017664 has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
This quality improvement project will include a practice change based on national guidelines for the nutritional management of PICU patients.
Primary Outcome
Daily total formula volume (mL) delivered
Interventions
- OTHER Peptide-based enteral formula
- OTHER Retrospective review of enteral tube feeding formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-01-15 |
| Est. Completion | 2019-12-31 |
What the finished NCT03017664 record still lists
NCT03017664 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Peptide-based enteral formula is the first listed.
NCT03017664 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03017664 about?
NCT03017664 is a clinical study titled "Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding". This quality improvement project will include a practice change based on national guidelines for the nutritional management of PICU patients.
What is the current status of trial NCT03017664?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2018-01-15. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03017664?
The interventions under investigation include: Peptide-based enteral formula (OTHER), Retrospective review of enteral tube feeding formula (OTHER).
Who is sponsoring clinical trial NCT03017664?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI